{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:46:28Z","timestamp":1790779588661,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1059-1","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T06:45:54Z","timestamp":1529390754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3206-707X","authenticated-orcid":false,"given":"Ang\u00e8le","family":"Dubouloz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Rouzaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lev","family":"Tsvang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilko","family":"Verbakel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Bj\u00f6rkqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Linthout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Lencart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Mar\u00eda","family":"P\u00e9rez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Escude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Miralbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"1059_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ijrobp.2010.11.054","volume":"82","author":"CR King","year":"2012","unstructured":"King CR, Brooks JD, Gill H, et al. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2012;82:877\u201382.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1059_CR2","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.ijrobp.2010.10.075","volume":"82","author":"R Miralbell","year":"2012","unstructured":"Miralbell R, Roberts SA, Zubizarreta E, et al. Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: alpha\/beta = 1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys. 2012;82:e17\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1059_CR3","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0360-3016(01)01607-8","volume":"50","author":"J Fowler","year":"2001","unstructured":"Fowler J, Chappell R. Ritter M. Is alpha\/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys. 2001;50:1021\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1059_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1748-717X-9-118","volume":"9","author":"S Shimizu","year":"2014","unstructured":"Shimizu S, Nishioka K, Suzuki R, et al. Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system. Radiat Oncol. 2014;9:118.","journal-title":"Radiat Oncol"},{"key":"1059_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1748-717X-8-58","volume":"8","author":"LN Chen","year":"2013","unstructured":"Chen LN, Suy S, Uhm S, et al. Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience. Radiat Oncol. 2013;8:58.","journal-title":"Radiat Oncol"},{"key":"1059_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1748-717X-7-82","volume":"7","author":"J Vainshtein","year":"2012","unstructured":"Vainshtein J, Abu-Isa E, Olson KB, et al. Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy. Radiat Oncol. 2012;7:82.","journal-title":"Radiat Oncol"},{"key":"1059_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ijrobp.2014.03.012","volume":"89","author":"DW Kim","year":"2014","unstructured":"Kim DW, Cho LC, Straka C, et al. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2014;89:509\u201317.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1059_CR8","doi-asserted-by":"crossref","unstructured":"Wortel RC, Heemsbergen WD, Smeenk RJ, et al. Local protocol variations for image-guided radiotherapy in the multicenter Dutch hypofractionation (HYPRO) trial: impact of rectal balloon and MRI delineation on anorectal dose and gastrointestinal toxicity levels. International Journal of Radiation Oncology*Biology*Physics. 2017;","DOI":"10.1016\/j.ijrobp.2017.07.044"},{"key":"1059_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.radonc.2009.08.011","volume":"93","author":"D Wolff","year":"2009","unstructured":"Wolff D, Stieler F, Welzel G, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2009;93:226\u201333.","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology."},{"key":"1059_CR10","doi-asserted-by":"crossref","unstructured":"Smeenk RJ, Teh BS, Butler EB, et al. is there a role for endorectal balloons in prostate radiotherapy? A systematic review. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2010;95:277\u2013282.","DOI":"10.1016\/j.radonc.2010.04.016"},{"key":"1059_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijrobp.2012.11.027","volume":"86","author":"O Chapet","year":"2013","unstructured":"Chapet O, Udrescu C, Devonec M, et al. Prostate hypofractionated radiation therapy: injection of hyaluronic acid to better preserve the rectal wall. Int J Radiat Oncol Biol Phys. 2013;86:72\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1059_CR12","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1016\/j.ijrobp.2012.03.028","volume":"84","author":"DC Weber","year":"2012","unstructured":"Weber DC, Zilli T, Vallee JP, et al. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study. Int J Radiat Oncol Biol Phys. 2012;84:e311\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1059_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3109\/02841861003745535","volume":"49","author":"U Isacsson","year":"2010","unstructured":"Isacsson U, Nilsson K, Asplund S, et al. A method to separate the rectum from the prostate during proton beam radiotherapy of prostate cancer patients. Acta Oncol. 2010;49:500\u20135.","journal-title":"Acta Oncol"},{"key":"1059_CR14","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ijrobp.2011.07.028","volume":"83","author":"RJ Smeenk","year":"2012","unstructured":"Smeenk RJ, Louwe RJ, Langen KM, et al. An endorectal balloon reduces intrafraction prostate motion during radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83:661\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1059_CR15","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","volume":"83","author":"HA Gay","year":"2012","unstructured":"Gay HA, Barthold HJ, O'Meara E, et al. Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas. Int J Radiat Oncol Biol Phys. 2012;83:e353\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1059_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0167-8140(03)00056-2","volume":"67","author":"RR Patel","year":"2003","unstructured":"Patel RR, Orton N, Tome WA, et al. Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2003;67:285\u201394.","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology."},{"key":"1059_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ijrobp.2005.05.010","volume":"63","author":"EN van Lin","year":"2005","unstructured":"van Lin EN, Hoffmann AL, van Kollenburg P, et al. Rectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63:565\u201376.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1059_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.radonc.2009.05.014","volume":"93","author":"RJ Smeenk","year":"2009","unstructured":"Smeenk RJ, van Lin EN, van Kollenburg P, et al. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2009;93:131\u20136.","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology."},{"key":"1059_CR19","doi-asserted-by":"crossref","unstructured":"Wong AT, Schreiber D, Agarwal M, et al. Impact of the use of an endorectal balloon on rectal dosimetry during stereotactic body radiation therapy for localized prostate cancer. Practical radiation oncology. 2015","DOI":"10.1016\/j.ijrobp.2015.07.1956"},{"key":"1059_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/acm2.12063","volume":"18","author":"HF Xiang","year":"2017","unstructured":"Xiang HF, Lu HM, Efstathiou JA, et al. Dosimetric impacts of endorectal balloon in CyberKnife stereotactic body radiation therapy (SBRT) for early-stage prostate cancer. Journal of applied clinical medical physics. 2017;18:37\u201343.","journal-title":"Journal of applied clinical medical physics"},{"key":"1059_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ijrobp.2006.09.034","volume":"67","author":"EN van Lin","year":"2007","unstructured":"van Lin EN, Kristinsson J, Philippens ME, et al. Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy. Int J Radiat Oncol Biol Phys. 2007;67:799\u2013811.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1059_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ijrobp.2013.10.039","volume":"88","author":"O Chapet","year":"2014","unstructured":"Chapet O, Udrescu C, Tanguy R, et al. Dosimetric implications of an injection of hyaluronic acid for preserving the Rectal Wall in prostate stereotactic body radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 2014;88:425\u201332.","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"1059_CR23","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20140736","volume":"88","author":"R Ruggieri","year":"2015","unstructured":"Ruggieri R, Naccarato S, Stavrev P, et al. Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer. Br J Radiol. 2015;88:20140736.","journal-title":"Br J Radiol"},{"key":"1059_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.radonc.2013.09.020","volume":"109","author":"W Lechner","year":"2013","unstructured":"Lechner W, Kragl G, Georg D. Evaluation of treatment plan quality of IMRT and VMAT with and without flattening filter using Pareto optimal fronts. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2013;109:437\u201341.","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"1059_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00066-015-0822-6","volume":"191","author":"C Marino","year":"2015","unstructured":"Marino C, Villaggi E, Maggi G, et al. A feasibility dosimetric study on prostate cancer : are we ready for a multicenter clinical trial on SBRT? Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al]. 2015;191:573\u201381.","journal-title":"Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al]"},{"key":"1059_CR26","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/j.ijrobp.2010.12.007","volume":"82","author":"DL Craft","year":"2012","unstructured":"Craft DL, Hong TS, Shih HA, et al. Improved planning time and plan quality through multicriteria optimization for intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82:e83\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1059-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T19:25:24Z","timestamp":1560885924000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1059-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1059-1","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"7 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is a dosimetric sub-study from a prospective multicentric randomized phase-II trial ( Identifier NCT01764646). The trial obtained the ethics approval from Geneva Univeristy Hospital Protocole 11\u2013196 (NAC 11\u2013089).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained written informed consent to publish from patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"114"}}